The City of Perth recently caught up with some of the leading professionals within the city’s Medical Life Sciences sector to create this short video. Here, we learn about the collaborative story of Dimerix – a client of Wrays’ and a shining example of how a biopharmaceutical company with origins in Perth can positively effect millions of people globally. We’re …
New Association Launched – Life Sciences WA Inc.
www.lifescienceswa.com.au On Thursday 25th February 2021, a new Association, Life Sciences WA Inc. was launched in Western Australia. This not-for-profit association seeks to bring together those involved in the Life Sciences sector in Western Australia. Details of the association can be found at www.lifescienceswa.com.au. Life Sciences WA Inc has been created to provide a collective representation for the Western Australian …
Wrays’ Trade Mark Team Elevated to Silver Ranking in the 2021 Edition of WTR1000
We are thrilled to announce that Wrays’ Trade Marks team have once again been recognised in the World Trademark Review 1000: The World’s Leading Trademark Professionals. The WTR 1000 research directory, which focuses exclusively on trademark practices and practitioners, has firmly established itself as the definitive ‘go-to’ resource for those seeking world-class legal trademark expertise. Rising from a bronze position in …
Perth Start-up Develops Innovative Mass COVID-19 Screening Technology
Western Australian start-up Avicena Systems is behind an innovative COVID testing technology, which has the potential to deliver a rapid, low-cost and large-scale alternative to the current screening system. The state of the art technology has the ability to test 100,000 people a day and provide a result in just half an hour. To put that into perspective, 300 machines …
Australian Trade Marks Update
This article discusses the recent trade marks office decision of Holdings of IP Pty Ltd AFT Intelligent Assets Trust v Joseph Buttita [2020] ATMO 169. During Melbourne’s strict lockdown, my partner and I being avid coffee lovers, purchased a new coffee machine. Every couple of weeks we venture down to our local café around the corner and purchase some coffee beans …
Growth for Drug Trials in COVID-free WA
Wrays is delighted to see Linear Clinical Research receiving recognition in the latest edition of Business News. The Nedlands-based drug testing company is about to launch an expansion to nearly double capacity as WA attracts attention from global pharmaceutical companies. Linear’s expansion comes at a time when an estimated 80 per cent of non-COVID drug tests have been cancelled this year, …
Asahi Succeeds in Defending the Allowability of Its Post-Acceptance Claim Amendments in Opposition Proceedings Brought by EMD
In the latest Australian Patent Office decision to consider the allowability of post-acceptance amendments, the patent applicant, Asahi Kasei Medical Co., Ltd. (Asahi), prevailed over the opponent EMD Millipore Corporation (EMD) in defending its amended claims. EMD opposed the grant of Asahi’s patent application for a porous membrane that is useful for removing, by filtration, viruses and other pathogens from …
Wrays Promotes Two Life Sciences Attorneys
Wrays is delighted to announce the promotion of two attorneys from our Life Sciences team. Dr Penelope Farbey has been promoted to Special Counsel and Dr Daniel Beck has been promoted to Associate. Dr Penelope Farbey joined Wrays in 2001 and is a molecular microbiology specialist, working closely with small to medium biotechnology, pharmaceutical and agri-biotech firms as well as …
Western Australia’s Impact on World Pharmaceutical Market
For Immediate Release Wrays congratulates their client Dimerix, a Western Australian clinical-stage biopharmaceutical company on the successful stage 2 clinical trial results for their product DMX-200 for the treatment of diabetic kidney disease. The trial results were announced 29 July 2020 and showed positive top-line results for a rare kidney disorder that often leads to end-stage kidney failure. Wrays, one …
Recognition for Wrays, IAM Patent 1000 2020 Rankings
Intellectual Asset Management’s (IAM) Patent 1000 annual patent rankings have just been released. Wrays is pleased to advise that we have been recognised as one of Australia’s leading patents firms delivering exceptional IP services with profound insight in patent matters. The IAM Patent 1000 rankings are regarded as the definitive directory for those seeking to identify world-class, private practice patent …